SCHEMBL31729003

SCHEMBL31729003

O=C1CC2(CCC2)CN1c1nc(-c2ccc(F)c(Cl)c2F)c2ncnc(O)c2n1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.36
▸ SSTR5 P35346 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728518 0.78 GRM5 (0.37) GRM5SSTR5
SCHEMBL31728134 0.78 PTPN11 (0.35) GRM5SSTR5
SCHEMBL31728909 0.74 PTPN11 (0.32) —
SCHEMBL31729228 0.64 LRRK2 (0.39) —
SCHEMBL31728618 0.58 CLK1 (0.36) —
SCHEMBL31729163 0.57 CLK1 (0.37) —
SCHEMBL31727874 0.57 CLK1 (0.38) —
SCHEMBL31728018 0.56 CLK1 (0.36) —
SCHEMBL31728133 0.56 CLK1 (0.36) —
SCHEMBL31728069 0.54 CLK1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback